Didanosine (Compound)

Synonyms:didanosine, 2',3'-Dideoxyinosine, 69655-05-6, DIDEOXYINOSINE, Videx, Videx EC, Inosine, 2',3'-dideoxy-, ddIno, Didanosina, Didanosinum, DDI, 2,3-dideoxyinosine, BMY-40900, UNII-K3GDH6OH08, 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one, NSC-612049, K3GDH6OH08, 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one, CHEBI:490877, 9-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-ol, NSC 612049, MFCD00077728, 9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE, NCGC00090691-03, NCGC00159514-02, DSSTox_CID_2927, 9-((2R,5S)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one, 9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one, DSSTox_RID_76791, DSSTox_GSID_22927, 2',3'-Dideoxyinosine (ddI), Hypoxanthine ddN, Didanosinum [INN-Latin], NSC612049, Didanosina [INN-Spanish], 9-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-6,9-DIHYDRO-3H-PURIN-6-ONE, D2I, SMR000058576, Videx(TM), Intron A & Videx, CAS-69655-05-6, Videx (TN), PC-SOD+ddI, Dideoxyinosine (DDI), LOA & ddI, ddI + d4T combination, ddI & GM-CSF, SR-05000001487, DRG-0016, DDI and rIFN.alpha.2, BMY 40900, ddI & sCD4(rsCD4), 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one, CCRIS 805, 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one, DS-4152 & ddI, HSDB 6548, Didanosine,(S), Didanosine [USAN:USP:INN:BAN], Didanosine (DDI), 9-(2,3-Dideoxy-beta-D-ribofuranosyl)-6-oxopurine, Didanosine (Videx), Didanosine and Interferon-.alpha.-2, Videx EC(TM)(slow-release capsules), KS-1049, BRN 3619529, 2',3'-didesoxyinosin, 2',3'-Dideoxyinosine (AIDS Initiative), ddI & IFN-.alpha., 2', 3'-dideoxyinosine, SCHEMBL3363, CHEMBL1460, 9-(2,3-Dideoxy-beta-D-ribofuranosyl)hypoxanthine, Listera ovata agglutinin & 2',3'-Dideoxyinosine, Didanosine (JAN/USP/INN), MLS000759469, MLS001055350, MLS001424118, MLS002154216, MLS006011561, 3'-Azido-3'-deoxythymidine + 2',3'-Dideoxyinosine, GTPL4833, DTXSID6022927, 2',3'-Dideoxyinosine & sCD4(soluble recombinant protein), HMS2051J11, HMS2089N20, HMS2095O08, HMS2232P22, HMS3712O08, HMS3884M06, HY-B0249, Didanosine system suitability mixture, Tox21_111732, Tox21_202333, Tox21_300575, 9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one, BDBM50404252, Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxyinosine, ZINC13597823, 2',3'-Dideoxyinosine & Granulocyte-macrophage colony-stimulating factor
Pubchem:PUBCHEM:135398739
Id:135398739
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Didanosine's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Didanosine.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Didanosine.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.